C4 Therapeutics, Inc share price logo

C4 Therapeutics, Inc Share Price

NASDAQ: CCCC

Small Cap

$2.21

+0.19

(+9.16%)

as on

C4 Therapeutics, Inc Stock Performance

as on October 16, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $2.03
    $2.22
    downward going graph

    8.14%

    Downside

    0.45%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.09
    $7.14
    downward going graph

    50.90%

    Downside

    223.08%

    Upside

    downward going graph

C4 Therapeutics, Inc share price movements today

Previous Close
$2.02
Open
$2.03
Volume
1.6M
Day's Low - High
$2.03 - $2.22
52 Week Low - High
$1.09 - $7.14

C4 Therapeutics, Inc Historical Returns

1 Month Return
-34.9 %
3 Month Return
+ 9.9 %
1 Year Return
-68.29 %
3 Year Return
-72.11 %
5 Year Return
-91.17 %

C4 Therapeutics, Inc Stock Fundamentals & Key Indicators

Check C4 Therapeutics, Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$143.8M

EPS (TTM)

-1.512

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-4.13

Industry PE ratio

-0.32286624203821657

PEG Ratio

0

EBITDA

-121.6M

Revenue (TTM)

34.2M

Profit Margin

0.00%

Return On Equity TTM

0.00%

C4 Therapeutics, Inc Stock Valuation

Track how C4 Therapeutics, Inc P/E has moved over time to understand its valuation trends.

C4 Therapeutics, Inc in the last 5 years

  • Overview

  • Trends

Lowest (-27.63x)

September 30, 2021

Today (-4.13x)

October 16, 2025

Industry (-0.32x)

October 16, 2025

Highest (-0.86x)

December 31, 2023

LowHigh

Today’s Price to Earnings Ratio: -4.13x

C4 Therapeutics, Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of C4 Therapeutics, Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$143.8M-91.17%-4.130.00%
BUY$61.5B223.43%-505.15-12.96%
NA$37.1BNANA-3.89%
BUY$105.7B87.04%28.9931.86%
BUY$59.6B-3.89%14.0731.37%

Stock Returns calculator for C4 Therapeutics, Inc Stock including INR - Dollar returns

The C4 Therapeutics, Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

C4 Therapeutics, Inc investment value today

Current value as on today

₹36,403

Returns

₹63,597

(-63.6%)

Returns from C4 Therapeutics, Inc Stock

₹68,429 (-68.43%)

Dollar Returns*

₹4,831 (+4.83%)

Analyst Recommendation on C4 Therapeutics, Inc Stock

Based on 15 analysts

BUY

73.33%

Buy

26.67%

Hold

0.00%

Sell

Based on 15 analysts, 73.33% of analysts recommend a 'BUY' rating for C4 Therapeutics, Inc. Average target price of $15

C4 Therapeutics, Inc Share Price Target

Get share price movements and forecasts by analysts on C4 Therapeutics, Inc.

What analysts predicted

85.27%UPSIDE

Target Price

$15

Current Price

$2.21

Analyzed by

15 Analysts

Target

$15.00

C4 Therapeutics, Inc target price $15, a slight upside of 85.27% compared to current price of $2.21. According to 15 analysts rating.

C4 Therapeutics, Inc Stock’s Investor Sentiment and Interest

Search interest for C4 Therapeutics, Inc Stock has decreased by -21% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-21% versus previous 30 day period

C4 Therapeutics, Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
3
2
11
3
3
12
15
5
7
6
Gross Profit
1
0
9
1
1
9
13
3
7
6
Operating Income
-36
-37
-27
-37
-32
-21
-28
-37
-29
-28
EBITDA
-32
-33
-23
-32
-26
-15
-22
-32
-28
-28
Interest Expense
0
0
0
2
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-34
-35
-26
-34
-28
-17
-24
-34
-26
-26
Income Tax Expense
0
1
-1
0
-2
-2
-2
0
-
-
Net Income
-33
-35
-27
-34
-28
-17
-24
-34
-26
-26
Net Profit Margin
-902.85%
-1348.42%
-244.19%
-1065.75%
-933.23%
-147.56%
-160.57%
-667.82%
-363.66%
-402.60%

C4 Therapeutics, Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
19
21
33
45
31
20
35
Gross Profit
-9
-26
-45
42
23
13
35
Operating Income
-16
-35
-60
-82
-129
-139
-119
EBITDA
-15
-30
-62
-78
-124
-122
-103
Interest Expense
-
2
1
2
2
1
-
Depreciation
1
1
1
1
1
1
1
Income Before Tax
-15
-33
-66
-83
-128
-131
-105
Income Tax Expense
0
0
0
2
-1
1
0
Net Income
-15
-34
-66
-83
-128
-132
-105
Net Profit Margin
-81.14%
-159.48%
-199.83%
-183.23%
-412.19%
-638.34%
-295.96%

C4 Therapeutics, Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-35
-27
-34
-28
-17
-24
-34
-26
-26
Operating Cash Flow
-18
-30
-24
-18
-4
-24
-17
-33
-12
Investing Cash Flow
15
57
31
-53
-11
0
13
29
38
Financing Cash Flow
0
-10
57
34
0
10
0
0
-
Change in Cash
-4
16
65
-36
-16
-13
-4
-4
26

C4 Therapeutics, Inc Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-34
-66
-83
-128
-132
-105
Operating Cash Flow
55
-67
-86
-105
-106
-65
Investing Cash Flow
-1
-190
-189
58
158
-51
Financing Cash Flow
0
348
171
1
45
45
Change in Cash
54
91
-104
-46
97
-71

Global Institutional Holdings in C4 Therapeutics, Inc

Funds
Holdings
Wasatch Advisors LP
10.43%
Soleus Capital Management, L.P.
9.81%
Orbimed Advisors, LLC
9.6%
Morgan Stanley - Brokerage Accounts
6.68%
Vanguard Group Inc
4.24%

Insights on C4 Therapeutics, Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -34.57M → -26.02M (in $), with an average increase of 16.3% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 153.5% return, outperforming this stock by 225.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 56.5% return, outperforming this stock by 124.8%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 7.23M → 6.46M (in $), with an average decrease of 10.7% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, CCCC stock has moved down by -7.9%

About C4 Therapeutics, Inc

c4 therapeutics is an early stage drug discovery company whose mission is to harness targeted protein degradation to develop therapeutics for a broad range of diseases. the centerpiece of our approach is the degronimid® platform, which enables highly selective small molecule binders to target disease causing proteins and facilitate their rapid destruction and clearance from the cell through the natural ubiquitin/proteasome system.
OrganisationC4 Therapeutics, Inc
Headquarters490 Arsenal Way, Watertown, MA, United States, 02472
IndustryHealth Technology
CEOMr. Andrew J. Hirsch M.B.A.
E-voting on sharesClick here to vote

Key Management of C4 Therapeutics, Inc

Name

Title

Ms. Kelly A. Schick

Chief People Officer

Mr. Andrew J. Hirsch M.B.A.

CEO, President & Director

Dr. Kenneth C. Anderson M.D., Ph.D.

Co-Founder, Independent Director & Member of Scientific Advisory Board

Dr. Leonard M. J. Reyno M.D.

Chief Medical Officer

Dr. Nathanael S. Gray Ph.D.

Co-Founder & Member of Scientific Advisory Board

Ms. Paige Mahaney Ph.D.

Chief Scientific Officer

Ms. Courtney Solberg

Senior Manager of Investor Relations

Ms. Jolie M. Siegel J.D.

Chief Legal Officer & Corporate Secretary

Ms. Kendra Adams

CFO & Treasurer

Mr. Mark Mossler

Chief Accounting Officer

FAQs

What is C4 Therapeutics, Inc share price today?

C4 Therapeutics, Inc share price today is $2.21 as on at the close of the market. C4 Therapeutics, Inc share today touched a day high of $2.22 and a low of $2.03.

What is the 52 week high and 52 week low for C4 Therapeutics, Inc share?

C4 Therapeutics, Inc share touched a 52 week high of $7.14 on and a 52 week low of $1.09 on . C4 Therapeutics, Inc stock price today i.e. is closed at $2.21,which is 69.05% down from its 52 week high and 103.69% up from its 52 week low.

What is C4 Therapeutics, Inc's market capitalisation today?

C4 Therapeutics, Inc market capitalisation is $0.00T as on .

How to invest in C4 Therapeutics, Inc Stock (CCCC) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for C4 Therapeutics, Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in C4 Therapeutics, Inc Shares that will get you 0.6787 shares as per C4 Therapeutics, Inc share price of $2.21 per share as on October 16, 2025 at 1:29 am IST.

What is the minimum amount required to buy C4 Therapeutics, Inc Stock (CCCC) from India?

Indian investors can start investing in C4 Therapeutics, Inc (CCCC) shares with as little as ₹87.985 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹879.85 in C4 Therapeutics, Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on C4 Therapeutics, Inc share’s latest price of $2.21 as on October 16, 2025 at 1:29 am IST, you will get 4.5249 shares of C4 Therapeutics, Inc. Learn more about fractional shares .

What are the returns that C4 Therapeutics, Inc has given to Indian investors in the last 5 years?

C4 Therapeutics, Inc stock has given -91.17% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?